<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Cannabinoid Research References</title>
    <style>
    body {
        font-family: Arial, sans-serif;
        line-height: 1.6;
        max-width: 800px;
        margin: 0 auto;
        padding: 20px;
        background: 
            linear-gradient(45deg, rgba(30, 64, 34, 0.1) 0%, rgba(76, 117, 76, 0.1) 100%),
            url('data:image/svg+xml;utf8,<svg viewBox="0 0 100 100" xmlns="http://www.w3.org/2000/svg"><circle cx="50" cy="50" r="40" stroke="%233B5249" stroke-width="2" fill="none"/><path d="M30,30 L70,70 M30,70 L70,30" stroke="%233B5249" stroke-width="2"/></svg>'),
            #f5f5f5;
        background-size: 40px 40px;
    }

    .container {
        background-color: rgba(255, 255, 255, 0.95);
        backdrop-filter: blur(3px);
        padding: 30px;
        border-radius: 10px;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }

    /* Add this new animation code */
    @keyframes float {
        0% { transform: translateY(0); }
        50% { transform: translateY(-20px); }
        100% { transform: translateY(0); }
    }

    .molecule {
        position: fixed;
        opacity: 0.1;
        animation: float 15s infinite;
        z-index: -1;
    }

    #molecule1 { left: 10%; top: 20%; }
    #molecule2 { right: 15%; top: 60%; }

    /* Keep all your existing other styles below */
    h1 { ... }
    .reference { ... }
    /* ... etc ... */
</style>
</head>
<body>
    <div class="container">
        <h1>Cannabinoid Research References</h1>
        
        <div class="qr-container">
            <input type="text" id="website-url" 
                   placeholder="Enter website URL" 
                   value="https://chronoxzx.github.io/cannabinoid-references/">
            <div id="qrcode"></div>
        </div>

        <div class="references">
            <!-- Reference 1 -->
            <div class="reference" id="ref1">
                <h3>[1] García C, et al. (2016)</h3>
                <p><em>Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia</em></p>
                <p>British Journal of Pharmacology 173(13):2069-2079</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1111/bph.13215" target="_blank">10.1111/bph.13215</a></p>
            </div>

            <!-- Reference 2 -->
            <div class="reference" id="ref2">
                <h3>[2] Patricio F, et al. (2020)</h3>
                <p><em>Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson’s Disease</em></p>
                <p>Frontiers in Pharmacology 11</p>
                <p class="doi">DOI: <a href="https://doi.org/10.3389/fphar.2020.595635" target="_blank">10.3389/fphar.2020.595635</a></p>
            </div>

            <!-- Reference 3 -->
            <div class="reference" id="ref3">
                <h3>[3] Cooray R, et al. (2020)</h3>
                <p><em>Current aspects of the endocannabinoid system and targeted THC and CBD phytocannabinoids as potential therapeutics for Parkinson’s and Alzheimer’s diseases: a review</em></p>
                <p>Molecular Neurobiology 57(8):4878-4890</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1007/s12035-020-02054-6" target="_blank">10.1007/s12035-020-02054-6</a></p>
            </div>

            <!-- Reference 4 -->
            <div class="reference" id="ref4">
                <h3>[4] Stampanoni Bassi M, et al. (2017)</h3>
                <p><em>Cannabinoids in Parkinson’s disease</em></p>
                <p>Cannabis and Cannabinoid Research 2(1):21-29</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1089/can.2017.0002" target="_blank">10.1089/can.2017.0002</a></p>
            </div>

            <!-- Reference 5 -->
            <div class="reference" id="ref5">
                <h3>[5] Ye L, et al. (2019)</h3>
                <p><em>New Insights in Cannabinoid Receptor Structure and Signaling</em></p>
                <p>Current Molecular Pharmacology 12(3):239-248</p>
                <p class="doi">DOI: <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6864585/" target="_blank">10.2174/1874467212666190215112036</a></p>
            </div>

            <!-- Reference 6 -->
            <div class="reference" id="ref6">
                <h3>[6] de Almeida DL, Devi LA. (2020)</h3>
                <p><em>Diversity of molecular targets and signaling pathways for CBD</em></p>
                <p>Pharmacology Research & Perspectives 8(6):e00682</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1002/prp2.682" target="_blank">10.1002/prp2.682</a></p>
            </div>

            <!-- Reference 7 -->
            <div class="reference" id="ref7">
                <h3>[7] Wi R, et al. (2020)</h3>
                <p><em>Functional crosstalk between CB and TRPV1 receptors protects nigrostriatal dopaminergic neurons in the MPTP model of Parkinson’s disease</em></p>
                <p>Journal of Immunology Research 2020:5093493</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1155/2020/5093493" target="_blank">10.1155/2020/5093493</a></p>
            </div>

            <!-- Reference 8 -->
            <div class="reference" id="ref8">
                <h3>[8] Giuliano C, et al. (2021)</h3>
                <p><em>Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson’s Disease</em></p>
                <p>International Journal of Molecular Sciences 22(16):8920</p>
                <p class="doi">DOI: <a href="https://doi.org/10.3390/ijms22168920" target="_blank">10.3390/ijms22168920</a></p>
            </div>

            <!-- Reference 9 -->
            <div class="reference" id="ref9">
                <h3>[9] García C, et al. (2011)</h3>
                <p><em>Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson’s disease</em></p>
                <p>British Journal of Pharmacology 163(7):1495–1506</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1111/j.1476-5381.2011.01278.x" target="_blank">10.1111/j.1476-5381.2011.01278.x</a></p>
            </div>

            <!-- Reference 10 -->
            <div class="reference" id="ref10">
                <h3>[10] Peball M, et al. (2020)</h3>
                <p><em>Non-motor symptoms in Parkinson’s disease are reduced by nabilone</em></p>
                <p>Annals of Neurology 88(4):712-722</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1002/ana.25864" target="_blank">10.1002/ana.25864</a></p>
            </div>

            <!-- Reference 11 -->
            <div class="reference" id="ref11">
                <h3>[11] Viveros-Paredes JM, et al. (2019)</h3>
                <p><em>Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage</em></p>
                <p>Neurología 34(3):143-152</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1016/j.nrl.2016.11.003" target="_blank">10.1016/j.nrl.2016.11.003</a></p>
            </div>

            <!-- Reference 12 -->
            <div class="reference" id="ref12">
                <h3>[12] Ren S, et al. (2020)</h3>
                <p><em>Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors</em></p>
                <p>Acta Pharmacologica Sinica 41(10):1263-1271</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1038/s41401-020-0385-7" target="_blank">10.1038/s41401-020-0385-7</a></p>
            </div>
            
            <!-- Reference 13 -->            
            <div class="reference" id="ref13">
                <h3>[13] More SV, Choi DK. (2015)</h3>
                <p><em>Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotection</em></p>
                <p>Molecular Neurodegeneration 10:17</p>
                <p class="doi">DOI: <a href="https://doi.org/10.1186/s13024-015-0012-0" target="_blank">10.1186/s13024-015-0012-0</a></p>
            </div>
            
            <!-- Reference 14 -->
            <div class="reference" id="ref14">
                <h3>[14] Sousa A, DiFrancisco-Donoghue J. (2023)</h3>
                <p><em>Cannabidiol and Tetrahydrocannabinol Use in Parkinson's Disease: An Observational Pilot Study</em></p>
                <p>Cureus 15(7):e42391</p>
                <p class="doi">DOI: <a href="https://doi.org/10.7759/cureus.42391" target="_blank">10.7759/cureus.42391</a></p>
            </div>
            
            <!-- Reference 15 -->
            <div class="reference" id="ref15">
                <h3>[15] Basile MS, Mazzon E. (2022)</h3>
                <p><em>The Role of Cannabinoid Type 2 Receptors in Parkinson's Disease</em></p>
                <p>Biomedicines 10(11):2986</p>
                <p class="doi">DOI: <a href="https://doi.org/10.3390/biomedicines10112986" target="_blank">10.3390/biomedicines10112986</a></p>
            </div>
            
            <!-- Reference 16 -->
            <div class="reference" id="ref16">
                <h3>[16] Vuic B, et al. (2022)</h3>
                <p><em>Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential</em></p>
                <p>Biomedicines 10(12):3000</p>
                <p class="doi">DOI: <a href="https://doi.org/10.3390/biomedicines10123000" target="_blank">10.3390/biomedicines10123000</a></p>
            </div>
        </div>
    </div>

    <script src="https://cdn.rawgit.com/davidshimjs/qrcodejs/gh-pages/qrcode.min.js"></script>
    <script>
        // ... (keep the same JavaScript code as before) ...
    </script>
    <svg class="molecule" id="molecule1" width="100" height="100" viewBox="0 0 100 100">
        <circle cx="50" cy="50" r="8" fill="#3B5249"/>
        <line x1="50" y1="50" x2="30" y2="30" stroke="#3B5249" stroke-width="2"/>
        <circle cx="30" cy="30" r="6" fill="#5B8C5A"/>
        <line x1="50" y1="50" x2="70" y2="70" stroke="#3B5249" stroke-width="2"/>
        <circle cx="70" cy="70" r="6" fill="#5B8C5A"/>
    </svg>

    <svg class="molecule" id="molecule2" width="120" height="120" viewBox="0 0 100 100">
        <circle cx="50" cy="50" r="8" fill="#5B8C5A"/>
        <line x1="50" y1="50" x2="30" y2="30" stroke="#5B8C5A" stroke-width="2"/>
        <circle cx="30" cy="30" r="6" fill="#3B5249"/>
        <line x1="50" y1="50" x2="70" y2="30" stroke="#5B8C5A" stroke-width="2"/>
        <circle cx="70" cy="30" r="6" fill="#3B5249"/>
    </svg>
</body>
</html>
